Dynamic MR imaging for functional vascularization depends on tissue factor signaling in glioblastoma

References

• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507. doi:10.1056/NEJMra0708126. PMID:18669428.
   PubMed Web of Science ®Google Scholar
• Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res: An official journal of the American Association for Cancer Research. 2004; 10:8177–84. doi:10.1158/1078-0432.CCR-04-1081. PMID:15623592.
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. doi:10.1016/S1470-2045(09)70025-7. PMID:19269895.
   PubMed Web of Science ®Google Scholar
• Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest; A Journal of Technical Methods and Pathology. 2004;84:397–405. doi:10.1038/labinvest.3700070. PMID:14990981.
   PubMed Web of Science ®Google Scholar
• Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, et al. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol. 2012;33:69–76. doi:10.3174/ajnr.A2743. PMID:22095961.
   PubMed Web of Science ®Google Scholar
• Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber G, Rossler K, et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol. 2003; 13:133–43. doi:10.1111/j.1750-3639.2003.tb00013.x. PMID:12744467.
   PubMed Web of Science ®Google Scholar
• Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol. 2002;28:57–66. doi:10.1046/j.1365-2990.2002.00367.x. PMID:11849564.
   PubMed Web of Science ®Google Scholar
• Chen L, Lin ZX, Lin GS, Zhou CF, Chen YP, Wang XF, Zheng ZQ. Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma. Human Pathol. 2015;46:120–8. doi:10.1016/j.humpath.2014.10.002. PMID:25455996.
   PubMed Web of Science ®Google Scholar
• Rivera LB, Bergers G. CANCER. Tumor angiogenesis, from foe to friend. Science. 2015;349:694–5.
   PubMed Web of Science ®Google Scholar
• Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, Pruschy M, Djonov V. Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am J Pathol. 2008;173:1173–85. doi:10.2353/ajpath.2008.071131. PMID:18787105.
   PubMed Web of Science ®Google Scholar
• Rak J, Yu JL, Luyendyk J, Mackman N. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res. 2006;66:10643–6. doi:10.1158/0008-5472.CAN-06-2350. PMID:17108099.
   PubMed Web of Science ®Google Scholar
• Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer. 1996;77:1877–83. doi:10.1002/(SICI)1097-0142(19960501)77:9%3c1877::AID-CNCR18%3e3.0.CO;2-X. PMID:8646688.
   PubMed Web of Science ®Google Scholar
• Guan M, Jin J, Su B, Liu WW, Lu Y. Tissue factor expression and angiogenesis in human glioma. Clin Biochem. 2002;35:321–5. doi:10.1016/S0009-9120(02)00312-0. PMID:12135696.
   PubMed Web of Science ®Google Scholar
• van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood. 2012; 119:924–32. doi:10.1182/blood-2011-06-317685. PMID:22065595.
   PubMed Web of Science ®Google Scholar
• Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol: Official Journal of the American Society of Clinical Oncology 2009;27:4834–8. doi:10.1200/JCO.2009.22.6324. PMID:19738116.
   PubMed Web of Science ®Google Scholar
• Magnus N, D'Asti E, Garnier D, Meehan B, Rak J. Brain neoplasms and coagulation. Semin Thromb Hemost. 2013;39:881–95. doi:10.1055/s-0033-1357483. PMID:24108471.
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Kucharzewska P, Christianson HC, Skold S, Lofstedt T, Johansson MC, Morgelin M, Bengzon J, Ruf W, Belting M. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A. 2011;108:13147–52. doi:10.1073/pnas.1104261108. PMID:21788507.
   PubMed Web of Science ®Google Scholar
• Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007; 8:610–22. doi:10.1038/nrn2175. PMID:17643088.
   PubMed Web of Science ®Google Scholar
• Carneiro-Lobo TC, Lima MT, Mariano-Oliveira A, Dutra-Oliveira A, Oba-Shinjo SM, Marie SK, Sogayar MC, Monteiro RQ. Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients. Oncol Rep. 2014;31:679–86. doi:10.3892/or.2013.2880. PMID:24297570.
   PubMed Web of Science ®Google Scholar
• Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, et al. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013;267:212–20. doi:10.1148/radiol.12120846. PMID:23238158.
   PubMed Web of Science ®Google Scholar
• Barajas RF, Jr., Hodgson JG, Chang JS, Vandenberg SR, Yeh RF, Parsa AT, McDermott MW, Berger MS, Dillon WP, Cha S. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology. 2010;254:564–76. doi:10.1148/radiol.09090663. PMID:20093527.
   PubMed Web of Science ®Google Scholar
• Jain R. Measurements of tumor vascular leakiness using DCE in brain tumors: Clinical applications. NMR Biomed. 2013;26:1042–9. doi:10.1002/nbm.2994. PMID:23832526.
   PubMed Web of Science ®Google Scholar
• Farrar CT, Kamoun WS, Ley CD, Kim YR, Kwon SJ, Dai G, Rosen BR, di Tomaso E, Jain RK, Sorensen AG. In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model. Neuro-oncology. 2010;12:341–50. doi:10.1093/neuonc/nop032. PMID:20308312.
   PubMed Web of Science ®Google Scholar
• Emblem KE, Mouridsen K, Bjornerud A, Farrar CT, Jennings D, Borra RJ, Wen PY, Ivy P, Batchelor TT, Rosen BR, et al. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat Med. 2013;19:1178–83. doi:10.1038/nm.3289. PMID:23955713.
   PubMed Web of Science ®Google Scholar
• Carneiro-Lobo TC, Konig S, Machado DE, Nasciutti LE, Forni MF, Francischetti IM, Sogayar MC, Monteiro RQ. Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. J Thromb Haemost: JTH. 2009;7:1855–64. doi:10.1111/j.1538-7836.2009.03553.x. PMID:19624457.
   PubMed Web of Science ®Google Scholar
• Jacobs VL, Valdes PA, Hickey WF, De Leo JA. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro. 2011;3:e00063. doi:10.1042/AN20110014. PMID:21740400.
   PubMed Web of Science ®Google Scholar
• de Vries NA, Beijnen JH, van Tellingen O. High-grade glioma mouse models and their applicability for preclinical testing. Cancer Treat Rev. 2009;35:714–23. doi:10.1016/j.ctrv.2009.08.011. PMID:19767151.
   PubMed Web of Science ®Google Scholar
• Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol. 2001;158:1145–60. doi:10.1016/S0002-9440(10)64062-X. PMID:11238063.
   PubMed Web of Science ®Google Scholar
• Dome B, Timar J, Paku S. A novel concept of glomeruloid body formation in experimental cerebral metastases. J Neuropathol Exp Neurol. 2003;62:655–61. doi:10.1093/jnen/62.6.655. PMID:12834110.
   PubMed Web of Science ®Google Scholar
• Straume O, Chappuis PO, Salvesen HB, Halvorsen OJ, Haukaas SA, Goffin JR, Begin LR, Foulkes WD, Akslen LA. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res. 2002;62:6808–11. PMID:12460889.
   PubMed Web of Science ®Google Scholar
• Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Sci. 1991;251:936–9. doi:10.1126/science.1840698. PMID:1840698.
   PubMed Web of Science ®Google Scholar
• Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A. 2011;108:3749–54. doi:10.1073/pnas.1014480108. PMID:21321221.
   PubMed Web of Science ®Google Scholar
• Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V, Tabruyn SP, You WK, Chapman HA, Christensen JG, et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov. 2012; 2:270–87. doi:10.1158/2159-8290.CD-11-0240. PMID:22585997.
   PubMed Web of Science ®Google Scholar
• Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012;22:21–35. doi:10.1016/j.ccr.2012.05.037. PMID:22789536.
   PubMed Web of Science ®Google Scholar
• Chen X, Fang J, Wang S, Liu H, Du X, Chen J, Li X, Yang Y, Zhang B, Zhang W. A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells. Oncotarget. 2014;5:1955–68. doi:10.18632/oncotarget.1885. PMID:24722469.
   PubMed Web of Science ®Google Scholar
• Kang HY, Xiao HL, Chen JH, Tan Y, Chen X, Xie T, Fang JQ, Wang S, Yang Y, Zhang WG. Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading. AJNR Am J Neuroradiol. 2016;37:51–7. doi:10.3174/ajnr.A4477. PMID:26381565.
   PubMed Web of Science ®Google Scholar
• Li X, Zhu Y, Kang H, Zhang Y, Liang H, Wang S, Zhang W. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging. Cancer Imaging: The Official Publication of the International Cancer Imaging Society 2015;15:4. doi:10.1186/s40644-015-0039-z. PMID:25889239.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. doi:10.1007/s00401-007-0243-4. PMID:17618441.
   PubMed Web of Science ®Google Scholar
• Fang J, Chen X, Zhang L, Chen J, Liang Y, Li X, Xiang J, Wang L, Guo G, Zhang B, et al. P2 × 7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway. Int J Biochem Cell Biol. 2013;45:1109–20. doi:10.1016/j.biocel.2013.03.005.
   PubMed Web of Science ®Google Scholar
• Fang J, Chen X, Wang S, Xie T, Du X, Liu H, Li X, Chen J, Zhang B, Liang H, et al. The expression of P2X(7) receptors in EPCs and their potential role in the targeting of EPCs to brain gliomas. Cancer Biol Ther. 2015;16:498–510. doi:10.1080/15384047.2015.1016663.
   PubMed Web of Science ®Google Scholar